{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:04:08Z","timestamp":1790784248483,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The optimal modality for predicting pathological complete response (pCR) after neoadjuvant therapy in rectal cancer remains uncertain. This study evaluated the ability of pre\u2011operative endoscopy and magnetic resonance imaging (MRI) to predict pCR and long\u2011term survival in stage II\/III rectal cancer following neoadjuvant treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective cohort study of a prospectively maintained database of patients with stage II\/III rectal cancer undergoing neoadjuvant therapy followed by surgery between 2016 and 2024 at a single institution. Patients underwent pre-operative endoscopic assessment and MRI restaging 4\u20138 weeks after completion of their neoadjuvant therapy, followed by surgery at 8\u201312 weeks. Endoscopic response was classified according to the Memorial Sloan Kettering schema. Strictures were classified as a separate phenotype. MRI tumour response was classified according to the tumour regression grade (TRG) score. Primary outcome was the pCR rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 203 patients, the overall pCR rate was 19.7%. pCR rates were 76.4% for cCR, 47.6% for nCR, 50% for strictures and 0% for iCR. Endoscopic response showed a greater discrimination for pCR compared to MRI TRG, (AUC 0.92 vs. 0.65,\n                      <jats:italic>z<\/jats:italic>\n                      = 5.74,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001). When cCR, nCR and strictures were grouped as \u201cgood endoscopic response\u201d and iCR as \u201cpoor response\u201d, 8-year OS was 80.1% versus 62.3% (\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 4.9,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.03) and 8-year DFS was 80.3% versus 60.4% (\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 6.2,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.01), with poor response associated with higher hazards of death and recurrence in Cox models. MRI TRG also stratified prognosis, and each one\u2011point increase in TRG was associated with a 2.31\u2011fold higher hazard of death and a 1.73\u2011fold higher hazard of a DFS event.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Endoscopic assessment provides a stronger predictor of pCR compared to MRI alone. Survival differences by response category suggest that intrinsic tumour biology, rather than delays in surgery, drives outcomes and supports careful WW surveillance for selected patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00464-026-13424-x","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:14:12Z","timestamp":1790781252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pre-operative endoscopic assessment and MRI as predictors of pathological complete response and long-term survival in locally advanced rectal cancer after neoadjuvant therapy"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3108-2649","authenticated-orcid":false,"given":"Trevor M.","family":"Yeung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Wa","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prudence","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Futaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie S.","family":"Hon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon S.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"issue":"4","key":"13424_CR1","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/ans.17475","volume":"92","author":"T McGiffin","year":"2022","unstructured":"McGiffin T, Clark DA, Edmundson A, Steffens D, Stevenson A, Solomon M (2022) Surgical management and long-term functional outcomes after anastomotic leak in patients undergoing minimally invasive restorative rectal resection and without a diverting ileostomy. ANZ J Surg 92(4):806\u2013812","journal-title":"ANZ J Surg"},{"issue":"6","key":"13424_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrac127","volume":"6","author":"S He","year":"2022","unstructured":"He S, Zhang J, Wang R, Li L, Shi L, Ren D et al (2022) Impact of long-course neoadjuvant radiation on postoperative low anterior resection syndrome and stoma status in rectal cancer: long-term functional follow-up of a randomized clinical trial. BJS Open 6(6):127","journal-title":"BJS Open"},{"issue":"4","key":"13424_CR3","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","volume":"240","author":"A Habr-Gama","year":"2004","unstructured":"Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U, Silva Sousa AH et al (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240(4):711\u2013717","journal-title":"Ann Surg"},{"issue":"4","key":"13424_CR4","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.ijrobp.2007.11.035","volume":"71","author":"A Habr-Gama","year":"2008","unstructured":"Habr-Gama A, Perez RO, Proscurshim I, Nunes Dos Santos RM, Kiss D, Gama-Rodrigues J et al (2008) Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome? Int J Radiat Oncol Biol Phys 71(4):1181\u20131188","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"13424_CR5","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ijrobp.2013.12.012","volume":"88","author":"A Habr-Gama","year":"2014","unstructured":"Habr-Gama A, Gama-Rodrigues J, S\u00e3o Juli\u00e3o GP, Proscurshim I, Sabbagh C, Lynn PB et al (2014) Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. Int J Radiat Oncol Biol Phys 88(4):822\u2013828","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"13424_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","volume":"22","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EM et al (2021) Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol 22(1):29\u201342","journal-title":"Lancet Oncol"},{"issue":"5","key":"13424_CR7","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","volume":"22","author":"T Conroy","year":"2021","unstructured":"Conroy T, Bosset JF, Etienne PL, Rio E, Fran\u00e7ois \u00c9, Mesgouez-Nebout N et al (2021) Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 22(5):702\u2013715","journal-title":"Lancet Oncol"},{"issue":"23","key":"13424_CR8","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1200\/JCO.22.00032","volume":"40","author":"J Garcia-Aguilar","year":"2022","unstructured":"Garcia-Aguilar J, Patil S, Gollub MJ, Kim JK, Yuval JB, Thompson HM et al (2022) Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol 40(23):2546\u20132556","journal-title":"J Clin Oncol"},{"key":"13424_CR9","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.1245\/s10434-025-17033-1","volume":"32","author":"CN Zivanov","year":"2025","unstructured":"Zivanov CN, Kau NS, Nalluri-Butz H, Oduyale OK, Eltahir AA, Yee JT et al (2025) Nonoperative management of rectal cancer: is \u201cnear-complete\u201d response safe to surveil? Ann Surg Oncol 32:4922","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"13424_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/DCR.0000000000003538","volume":"68","author":"RY Rosen","year":"2025","unstructured":"Rosen RY, Bercz AP, Omer DM, Verheij FS, Williams H, Malekzadeh P et al (2025) Correlation between grade of clinical response to neoadjuvant therapy for rectal cancer and oncologic outcomes in the era of watch-and-wait. Dis Colon Rectum 68(3):300\u2013307","journal-title":"Dis Colon Rectum"},{"issue":"11","key":"13424_CR11","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1111\/codi.15177","volume":"22","author":"G Simpson","year":"2020","unstructured":"Simpson G, Hopley P, Wilson J, Day N, Haworth A, Montazeri A et al (2020) Long-term outcomes of real world \u201cwatch and wait\u201d data for rectal cancer after neoadjuvant chemoradiotherapy. Colorectal Dis 22(11):1568\u20131576","journal-title":"Colorectal Dis"},{"issue":"3","key":"13424_CR12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/ans.19415","volume":"95","author":"STRATA Collaborative","year":"2025","unstructured":"STRATA Collaborative (2025) ACCORD study: a national multi-centre study of the watch and wait approach in patients with rectal cancer in Aotearoa New Zealand. ANZ J Surg 95(3):440\u2013449","journal-title":"ANZ J Surg"},{"issue":"4","key":"13424_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znaf040","volume":"112","author":"BM Geubels","year":"2025","unstructured":"Geubels BM, Grotenhuis BA, van den Esschert A-J, Lambregts DMJ, Maas M, Marijnen CAM et al (2025) National implementation of watch-and-wait in patients with rectal cancer. Br J Surg 112(4):40","journal-title":"Br J Surg"},{"issue":"1","key":"13424_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.50903","volume":"7","author":"HM Thompson","year":"2024","unstructured":"Thompson HM, Omer DM, Lin S, Kim JK, Yuval JB, Verheij FS et al (2024) Organ preservation and survival by clinical response grade in patients with rectal cancer treated with total neoadjuvant therapy: a secondary analysis of the OPRA randomized clinical trial. JAMA Netw Open 7(1):e2350903","journal-title":"JAMA Netw Open"},{"issue":"9","key":"13424_CR15","doi-asserted-by":"publisher","first-page":"5669","DOI":"10.1007\/s00464-025-11982-0","volume":"39","author":"TM Yeung","year":"2025","unstructured":"Yeung TM, Rosen RY, Bercz A, Williams H, Omer D, Verheij FS et al (2025) The value of MRI and flexible sigmoidoscopy in detecting tumor regrowth in watch and wait rectal cancer patients undergoing active surveillance after total neoadjuvant therapy. Surg Endosc 39(9):5669\u20135675","journal-title":"Surg Endosc"},{"issue":"1","key":"13424_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/27684520.2024.2322630","volume":"2","author":"L Ashour","year":"2024","unstructured":"Saban\u00e9s Bov\u00e9 D, Seibold H, Boulesteix AL, Manitz J, Gasparini A, G\u00fcnhan BK et al (2026) The statistical software revolution in pharmaceutical development: challenges and opportunities in open source. Drug Discov Today 31(2):104613","journal-title":"Res Stat"},{"issue":"1","key":"13424_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3393\/ac.2024.00339.0048","volume":"41","author":"N Shadmanov","year":"2025","unstructured":"Shadmanov N, Aliyev V, Piozzi GN, Bak\u0131r B, Goksel S, Asoglu O (2025) Is clinical complete response as accurate as pathological complete response in patients with mid-low locally advanced rectal cancer? Ann Coloproctol 41(1):57\u201367","journal-title":"Ann Coloproctol"},{"issue":"10","key":"13424_CR18","doi-asserted-by":"publisher","first-page":"106962","DOI":"10.1016\/j.ejso.2023.06.014","volume":"49","author":"C Cerd\u00e1n-Santacruz","year":"2023","unstructured":"Cerd\u00e1n-Santacruz C, Cano-Valderrama \u00d3, Santos Ranca\u00f1o R, Ter\u00e9s LB, Vigorita V, P\u00e9rez TP et al (2023) Long-term oncologic outcomes and risk factors for distant recurrence after pathologic complete response following neoadjuvant treatment for locally advanced rectal cancer. A nationwide, multicentre study. Eur J Surg Oncol 49(10):106962","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"13424_CR19","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s00432-017-2383-9","volume":"143","author":"WH Fan","year":"2017","unstructured":"Fan WH, Xiao J, An X, Jiang W, Li LR, Gao YH et al (2017) Patterns of recurrence in patients achieving pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancer. J Cancer Res Clin Oncol 143(8):1461\u20131467","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"13424_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/SLA.0b013e3182196e1f","volume":"254","author":"J Garcia-Aguilar","year":"2011","unstructured":"Garcia-Aguilar J, Smith DD, Avila K, Bergsland EK, Chu P, Krieg RM (2011) Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial. Ann Surg 254(1):97\u2013102","journal-title":"Ann Surg"},{"issue":"8","key":"13424_CR21","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S1470-2045(15)00004-2","volume":"16","author":"J Garcia-Aguilar","year":"2015","unstructured":"Garcia-Aguilar J, Chow OS, Smith DD, Marcet JE, Cataldo PA, Varma MG et al (2015) Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol 16(8):957\u2013966","journal-title":"Lancet Oncol"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-13424-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-026-13424-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-13424-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:14:13Z","timestamp":1790781253000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-026-13424-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":21,"alternative-id":["13424"],"URL":"https:\/\/doi.org\/10.1007\/s00464-026-13424-x","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"21 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors Trevor Yeung, Wing Wa Leung, Justin Lam, Prudence Tam, Julie Ng, Kaori Futaba, Sophie Hon, Simon Chu, Esther Hung, Carmen Cho and Simon Ng have no conflicts of interest or financial ties to disclose.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was carried out in accordance with Declaration of Helsinki of the World Medical Association and the International Conference on Harmonization\u2014Good Clinical Practice. Ethics approval for this study was granted by the Joint CUHK-NTEC Clinical Research Ethics Committee, CREC ref. 2026.505.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}